| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.045 | 0.1 |